Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

OGN Produkte

(Osteoglycin (OGN))

Kategorien

This gene encodes a protein which induces ectopic bone formation in conjunction with transforming growth factor beta. This protein is a small proteoglycan which contains tandem leucine-rich repeats (LRR). Alternatively spliced transcript variants that encode the same protein have been found for this gene. [provided by RefSeq, Jul 2008].

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Ausgewählte OGN Kategorien

OGN Antikörper

High quality antibodies with extensive validation data.

OGN ELISA Kits

Reliable ELISA kits for a wide range of species.

OGN Proteine

Proteins for various applications incl. WB, ELISA, IF etc.

Empfohlene OGN Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Mouse
Applikation WB, IHC, IP, ICC
Validierungen
  • (4)
Kat. Nr. ABIN7437323
Menge 100 μL
Datenblatt Datenblatt
Reaktivität Human
Applikation WB, IHC, IF
Validierungen
  • (4)
Kat. Nr. ABIN6145008
Menge 100 μL
Datenblatt Datenblatt
Reaktivität Human, Mouse, Rat
Applikation IHC, IF
Validierungen
  • (3)
Kat. Nr. ABIN7011291
Menge 60 μL
Datenblatt Datenblatt

Empfohlene OGN ELISA Kits

Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Analytical Method Quantitative Sandwich ELISA
Validierungen
  • (4)
  • (1)
Kat. Nr. ABIN6958343
Menge 96 tests
Datenblatt Datenblatt
Reaktivität Mouse
Analytical Method Quantitative Sandwich ELISA
Validierungen
  • (1)
  • (1)
Kat. Nr. ABIN6958344
Menge 96 tests
Datenblatt Datenblatt
Reaktivität Human
Analytical Method Quantitative Sandwich ELISA
Validierungen
  • (1)
Kat. Nr. ABIN6962512
Menge 96 tests
Datenblatt Datenblatt

Empfohlene OGN Proteine

Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Source Wheat germ
Validierungen
  • (1)
Kat. Nr. ABIN1313357
Menge 10 μg
Datenblatt Datenblatt
Reaktivität Human
Source HEK-293 Cells
Validierungen
Kat. Nr. ABIN7504488
Menge 100 μg
Datenblatt Datenblatt
Reaktivität Human
Source Escherichia coli (E. coli)
Validierungen
Kat. Nr. ABIN7396676
Menge 100 μg
Datenblatt Datenblatt

Neueste Publikationen zu unseren OGN Produkten

Seki, Saita, Kishimoto, Ibe, Miyazaki, Miura, Ohmori, Ikegami, Kondo, Momiyama: "Low Levels of Plasma Osteoglycin in Patients with Complex Coronary Lesions." in: Journal of atherosclerosis and thrombosis, Vol. 25, Issue 11, pp. 1149-1155, (2019) (PubMed).

Baek, Cha, Kang, Park, Cha, Kim, Yoon, Kim, Han, Park, Chang, Lim, Kim, Na: "Higher Serum Levels of Osteoglycin Are Associated with All-Cause Mortality and Cardiovascular and Cerebrovascular Events in Patients with Advanced Chronic Kidney Disease." in: The Tohoku journal of experimental medicine, Vol. 242, Issue 4, pp. 281-290, (2018) (PubMed).

Hu, Li, Li, Ma, Peng, Cai: "Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway." in: Journal of experimental & clinical cancer research : CR, Vol. 37, Issue 1, pp. 41, (2018) (PubMed).

Lee, Ali, Zhang, Qi, Clarke, Enriquez, Brzozowska, Lee, Rogers, Laybutt, Center, Baldock, Herzog: "Osteoglycin, a novel coordinator of bone and glucose homeostasis." in: Molecular metabolism, Vol. 13, pp. 30-44, (2018) (PubMed).

Yang, Wu, Li, Gao: "Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients." in: Journal of human hypertension, Vol. 32, Issue 8-9, pp. 564-571, (2018) (PubMed).

Tanaka, Kanazawa, Kaji, Sugimoto: "Association of osteoglycin and FAM5C with bone turnover markers, bone mineral density, and vertebral fractures in postmenopausal women with type 2 diabetes mellitus." in: Bone, Vol. 95, pp. 5-10, (2016) (PubMed).

Van Aelst, Voss, Carai, van Leeuwen, Vanhoutte, Sanders-van Wijk, Eurlings, Swinnen, Verheyen, Verbeken, Nef, Troidl, Cook, Brunner-La Rocca, Möllmann, Papageorgiou, Heymans: "Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening." in: Circulation research, (2014) (PubMed).

Röwer, Ziems, Radtke, Schmitt, Reimer, Koy, Thiesen, Gerber, Glocker: "Toponostics of invasive ductal breast carcinoma: combination of spatial protein expression imaging and quantitative proteome signature analysis." in: International journal of clinical and experimental pathology, Vol. 4, Issue 5, pp. 454-67, (2011) (PubMed).

Bolander, Agnarsdóttir, Strömberg, Ponten, Hesselius, Uhlen, Bergqvist: "The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas." in: Cancer genomics & proteomics, Vol. 5, Issue 6, pp. 293-300, (2009) (PubMed).

Synonyme und alternative Namen zu OGN

osteoglycin (OGN), osteoglycin L homeolog (ogn.L), osteoglycin (ogn), osteoglycin (Ogn), 3110079A16Rik, MGC53032, mimecan, mimican, OG, OIF, si:ch211-103f16.4, SLRR3A, zgc:113545

Bezeichner auf Proteinebene für OGN

  • corneal keratan sulfate proteoglycan
  • mimecan
  • mimecan proteoglycan
  • osteoinductive factor
  • osteoglycin
  • osteoglycin (osteoinductive factor)
  • osteoglycin (osteoinductive factor, mimecan)
  • osteoglycin preproprotein
  • osteoglycin/mimecan
Sie sind hier:
Kundenservice